论文部分内容阅读
From Oct.2011, Institut Gustave Roussy (Pr Eggermont, CEO) launched an active collaboration in the cancer field with Chinese cancer hospitals/institutions, not only in scientific and clinical exchanges, but also in translational collaboration and new anticancer drug development.The main undergone and ongoing collaboratoring projects are open on 5 sites.